PUBLICATIONS

1) Mariottini, P., Bagni, C., Annesi, F. and Amaldi, F. (1988). "Isolation and nucleotide sequences of cDNAs for Xenopus laevis ribosomal protein S8: similarities in the 5' and 3' untranslated regions of mRNAs for various r-proteins". Gene, 67, 69-74.

2) Bagni, C., Mariottini, P., Annesi, F. and Amaldi, F. (1990). "Structure of Xenopus laevis ribosomal protein L32 and its expression during development". Nucleic Acid Res. 18, 4423-4426.

3) Mariottini, P., Annesi, F., Bagni, C., Chen Q.M., Francesconi, A., Pesce, C.D., Serra, M.J. and Amaldi, F. (1990). "Ribosomal protein genes in Xenopus laevis: organization, structure and identification of the cis-element responsible for their translational control". in "Nuclear structure and function". J.R. Harris ed., Plenum Publishing Co., New York, pp. 83-87.

4) Bagni, C., Mariottini, P., Terrenato, L. and Amaldi, F. (1992). "Individual variability in the translational regulation of ribosomal protein synthesis in Xenopus". Mol.Gen.Genet. 234, 60-64.

5) Chen, Q.M., Mariottini, P., Bagni, C. and Amaldi, F. (1992). "The pyrimidine sequence encompassing the transcription start point of Xenopus laevis genes encoding ribosomal proteins is not obligatory for the activity in oocytes" Gene 119, 283-286.

6) Mariottini, P., Bagni, C., Francesconi, A., Cecconi, F., Serra, M.J., Chen, Q.M., Loreni, F., Annesi, F. and Amaldi F. (1993). "Nucleotide sequence of the gene coding for the ribosomal protein S8 of Xenopus laevis". Gene 132, 255-260.

7) Bagni C., Mariottini P., Annesi F., Amaldi F. (1993). “Human ribosomal protein L4: cloning and sequencing of the cDNA and primary structure of the protein”. Bioch.Bioph.Acta 1216, 475-478.

8) Girard J.P., Bagni C., Caizergues-Ferrer M., Amalric F. and Lapeyre B. (1994). “Identification of a segment of the snoRNP protein GAR1 which is sufficient for nucleolar accumulation”. J.Biol.Chem. 269, 18499-18506.

9) Hsu T.*, Bagni C*., Sutherland J. and Kafatos F.C. (1996). "The transcription factor CF2 is a mediator of EGF-R activated dorsoventral patterning in Drosophila Oogenesis". Genes & Dev 10, 1411-1422. *First two authors contributed equally.

10) Bagni C. and Lapeyre B. (1998). “Gar1p binds to the small nucleolar RNAs snR10 AND snR30 in vitro through a novel RNA binding motif". J.Biol.Chem. 273, 18: 10868-10873.

11) Adinolfi, S., Bagni, C., Musco, G., Mazzarella, L and Pastore, A. (1999). "Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains". RNA 5, 1248-58.

12) Adinolfi S, Bagni C, Castiglione Morelli MA, Fraternali F, Musco G, Pastore A. (1999) "Novel RNA-binding motif: The KH module" Biopolymers 51:153-164

13) Mariottini P, ZH, Toivonen, JM., Bagni, C., Spelbrink, J.N., Amaldi, F and Jacobs, HT. (1999). "Expression of the gene for mitoribosomal protein S12 is controlled in human cells at the levels of transcription, RNA splicing and translation” J. Biol. Chem. 274, 31853-31862.

14) Bagni, C., Mannucci, L., Dotti, C. and Amaldi, F. (2000).“ Chemical stimulation of synaptosomes modulates a-CaMKII mRNA association to polysomes”.(J. Neurosci. 20, RC76 1-6.)

15) Cannata, SM., Bagni, C., Bernardini, S., Christen, B. and Filoni, S. (2001). "Nerve-independence of limb regeneration in larval Xenopus laevis is correlated to the level of FGF-2 mRNA expression in limb tissues. (Develop. Biol. 231, 436-446)

16) G. Pepe, B. Giusti, L. Evangelisti, M.C. Porciani, T. Brunelli, L. Giurlani, M. Attanasio, R. Fattori, C. Bagni, P. Comeglio, R. Abbate, G.F. Gensini. (2001).“Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype-phenotype correlations”. (Clin. Genet 59: 444-50).

17) Signori, E., Bagni, C., Primerano B., Papa, S., Rinaldi, M., Amaldi, F. and Fazio, V.M.(2001). "A somatic mutation in the 5' UTR of BRCA1 gene causes down-modulation of translation efficiency in an invasive sporadic breast cancer" (Oncogene 20 : 4596-600).

18) A. Schenck, B. Bardoni, A. Moro, C. Bagni and J-L Mandel (2001). “A highly conserved protein family interacting with the fragile X Mental Retardation Protein and displaying selective Interactions with the related proteins FXR1P and FXR2P” (Proc.Natl.Acad.Sci.98: 8844-9).

19) Bagni C, Gogos JA, Bray S, Kafatos FC and Hsu T. (2002). “The zinc finger protein CF2 functions downstream of MEF2 during muscle development in Drosophila”. Mech Dev. 117:265-268.

20) Primerano B, Tassone F, Hagerman P, Hagerman R, Amaldi F and Bagni C (2002). Reduced FMRP and increased FMR1 mRNA is proportionally associated with CGG repeat number and reflects a translational defect of the mRNA. RNA 8:1482-8.

21) Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta A., Surya R., Oostra, B., and Bagni, C. (2003). “The Fragile X Syndrome protein FMRP regulates the translation of specific mRNAs at the synspes via BC1 RNA” Cell 112, 317-327.

22) Zalfa F. and Bagni C. (2004) Molecular insights into mental retardation: multiple functions for the Fragile X Mental Retardation Protein? Curr. Issues in Mol. Biol. 6, 73-88.

23) Veneri M., Zalfa F. and Bagni C. (2004). “FMRP and its target RNAs: fishing for the specificity” . Neuroreport 15: 2447-2450.

24) Baldini P.M., De Vito P., Antenucci D., Vismara D., Cossa P., D’Aquilio F., Luly P., Zalfa F., Bagni C. and Di Nardo P. (2004). “Atrial Natriuretic Peptide decreases cell viability of HepG2 cells through the involvenent of NADPH oxidase”. Cell Death Differ. 11, Suppl 2: s210-212.

25) Baldini P.M., De Vito P., Vismara D., Luly P., Bagni C., Zalfa F., Minieri M. and Di Nardo P. (2004). “Atrial natriuretic peptide effects on intracellular pH changes and ROS production in HepG2 cells: role of p38 MAPK and phospholipase D”. Mol. Cellul. Biochem, 15, 77-88.

26) Baldini, PM, De Vito, P, D'aquilio, F, Vismara, D, Zalfa, F, Bagni, C, Fiaccavento, R, Di Nardo, P.  (2005). "Role of atrial natriuretic peptide in the suppression of lysophosphatydic acid-induced rat aortic smooth muscle (RASM) cell growth". Mol. Cell. Biochem. 272, 19-28.

27) Pietrobono, R, Tabolacci, E, Zalfa, F, Zito, I, Terracciano, A, Moscato, U, Bagni, C, Oostra, B, Chiurazzi, P and Neri, G (2005). "Molecular dissection of the events leading to inactivation of the FMR1 gene" Hum. Mol. Gen. 14,  267-277.

28) Zalfa, F. and Bagni, C. (2005). "Another view of the role of FMRP in translational regulation". Cell. Mol. Life Sci. 62,  251-252.

29) Bagni, C., Greenough, W.T. (2005) "From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome" Nat. Rev. Neurosci. 5, 376-387.

30) Restivo, L., Passino, E., Sgobio, C.A., Ferrari, F., Oostra, B., Bagni, C. and Ammassari-Teule*, M. (2005). "Environmental manipulations restore behavioural and neuronal morphology abnormalities in a mouse model of Fragile X Mental Retardation Sindrome". Proc. Natl. Acad. Sci. U.S.A. 102, 11557-11562.

31) Zalfa, F., Adinolfi, S., Napoli, I., Kuhn-Holsken, E., Urlaub, H., Achsel, T., Pastore, A., Bagni, C. (2005). "FMRP binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA binding motif." J. Biol. Chem, (in press).